YCYong Chen

Yong Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yong Chen has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Qiu Zhang

    Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University

    3 shared publications
  • Jihong Zhou

    College of Agricultural & Biotechnology, Zhejiang University, Hangzhou 310013, China

    2 shared publications
  • Linyang Li

    Department of the Fifth Tuberculosis, Chongqing Public Health Medical Center, Chongqing, 400030, People’s Republic of China

    2 shared publications
  • An-Zhou Peng

    Department of the Fifth Tuberculosis, Chongqing Public Health Medical Center, Chongqing, 400030, People’s Republic of China

    1 shared publication
  • Anzhou Peng

    Department of the Fifth Tuberculosis, Chongqing Public Health Medical Center, Chongqing, People’s Republic of China

    1 shared publication
  • Ao Yang

    Daping Hospital, Army Medical Center of the PLA, Research Institute of Surgery, Army Medical University, Chongqing, China

    1 shared publication

Latest Publications

  • Open Access

    Association Between Promoter Methylation of Vitamin D Metabolic Pathway Genes and Tuberculosis and Diabetes Comorbidity in a Chinese Han Population: A Case–Control Study

    by Yong Chen, An-Zhou Peng, Kun Li, Lei Liu, Fazhen Zhang, Jin Chen, Huifen Zhang, Linyang Li, Hailin Yang, Xihai Xu, et al.

    Background: Deficiency vitamin D and hyperglycemia could be related to weakened innate immune response and aggravate the progression of tuberculosis (TB). This study hypothesized that DNA promoter methylation of the pivotal genes in the vitamin D metabolic pathway might be related to diabetes and tuberculosis co-morbidity (TB-DM) susceptibility. Methods: A total of 50 TB-DM and 50 healthy subjects (HS) were included in the present study. Targeted bisulfite sequencing was applied to detect the methylation of the promoter regions of candidate genes in the vitamin D metabolic pathway (CYP24A1, CYP27B1, CYP2R1, DHCR7, and VDR) in whole blood. Results: The overall methylation level of candidate genes in this study was lower in patients with TB-DM than HS, except for CYP2R1. The results of the ROC demonstrated the potential of CYP24A1, CYP27B1, DHCR7, and VDR promoter methylation as a biomarker for diagnosing TB-DM, with all the AUC above 0.7. In subgroup analysis, we found that lower circulating vitamin D is related to a low level of CYP24A1, CYP27B1, and DHCR7 promoter methylation in patients with TB-DM. With decreasing methylation level, risk of TB-DM was significantly increased (odds ratio, 95% CI 0.343, 0.144– 0.821 for CYP24A1; 0.461, 0.275– 0.773 for CYP27B1; 0.09, 0.015– 0.530 for DHCR7; 0.006, 0.0003– 0.115 for VDR). Besides, our results revealed that there was a significant correlation between DNA promoter methylation of selected genes in the vitamin D metabolic pathway and platelet indices in TB-DM. However, there was no correlation between DNA methylation of the four genes and fasting glucose and HbA1c. Conclusion: Our results could suggest that the selected genes in the vitamin D metabolic pathway may be involved in the pathological process of TB-DM, but independent of the process of hyperglycemia to impaired immune responses to Mtb.


  • Open Access

    Clinical features and direct medical cost of splenic injury in China: a cross-sectional study

    by Yong Chen, Yan Liu, Yubo Ma, Yong Qi, Qiu Zhang, Ji-Hong Zhou

    Objectives This study analyses the clinical features and direct medical cost (DMC) of splenic injury during 2000–2013 in China. Design This was a cross-sectional study. Methods We used ‘The No. 1 Military Medical Project’ information system to conduct a retrospective study. Patients’ information from 2000 to 2013 were identified. Demographic data, treatment, clinical data and DMC were collected. We performed a generalised linear method (GLM) using gamma distribution to assess the drivers of DMCs. Results We included 8083 patients with splenic injury who met the study criteria. Over the 14-year study period, 2782 (34.4%) patients were treated with non-operative management (NOM), 5301 (65.6%) with OM. From 2000 to 2013, the rate of NOM increased from 34.7% to 55.9%, while OM decreased from 65.3% to 44.1%. Mean per-patient DMC in both NOM and OM increased from 2000 to 2013. In GLM analysis, male, old age, length of stay, severe splenic injury grade, OM, intensive care unit, blood transfusion and tertiary hospitals were associated with higher DMC, while female and NOM was associated with lower DMC. Conclusions In China, management of splenic injury was the most important factor impacting the total DMC. Proper management and public policy could curtail the burden of splenic injury.

  • Open Access

    Association of TyG Index with CT Features in Patients with Tuberculosis and Diabetes Mellitus

    by Yong Chen, Anzhou Peng, Yiqing Chen, Xianghua Kong, Linyang Li, Guangxiao Tang, Huifen Li, Yu Chen, Fan Jiang, Peibo Li, et al.

    Background: The purpose of this study was to investigate the association of the triglyceride glucose (TyG) index, a surrogate marker of insulin resistance (IR) with a high sensitivity of 96.5% and a specificity of 85.0% for the diagnosis of IR, with computed tomography (CT) features in patients with tuberculosis and diabetes mellitus. Methods: A total of 247 subjects were enrolled from July, 2020 to May, 2021. The basic clinical features and CT features were analyzed. In addition, multivariate logistic regression analysis models were employed to evaluate the association of the TyG indicator with CT features in participants. Results: In the quartile groups of TyG index, air bronchial sign detection rate was 11.7%, 14.5%, 23.2%, and 44.1%; large segmented leafy shadow detection rate was 27.9%, 40.6%, 46.4%, and 66.2%; thick-walled cavity was found in 38.2%, 43.4%, 57.9%, and 69.1%; the rate of multiple cavities was 17.6%, 27.5%, 36.2%, 52.9%; the rate of lymph node enlargement was 22.1%, 17.4%, 28.9%, and 38.2%, respectively. In addition, the positive relation with the TyG index and the prevalence of abnormal CT signs was observed in the fully adjusted model: TyG, per one-unit increase: air bronchial sign: adjusted odds ratio (AOR) 3.92, 95% CI 1– 15.35, P = 0.049; multiple cavities: AOR 4.1, 95% CI 1.26– 13.31, P = 0.019; thick-walled cavity: AOR 2.89, 95% CI 1.05– 8.03, P = 0.041. In quartile of TyG index, compared with patients in quartile 1, the AOR (95% CI) values for air bronchial sign in quartile 4 was 8.1 (1.7– 44), p = 0.011; multiple cavities was 7.1 (1.7– 32), p = 0.008; thick-walled cavity was 7.8 (1.9– 34.7), p = 0.005. Conclusion: The present study showed that an increased TyG index was positively related to the severity of patients with T2DM-PTB.


  • Open Access

    Epidemiology and management of splenic injury: An analysis of a Chinese military registry

    by Yong Chen, Jun Qiu, Ao Yang, Danfeng Yuan, Jihong Zhou

    In China, there have been few meta-analyses of the epidemiology and management of splenic injury. Due to the success of Chinese military hospitals in the domestic treatment of splenic injury, the present study conducted a systematic review of such cases, identifying a high occurrence rate of splenic trauma, as well as a number of strategies of managing splenic injury in China. Data were collected from sixteen Chinese military hospitals between July 2000 and March 2009, and retrospectively reviewed. It was observed that between July 2000 and March 2009 a total of 7,807 patients (84.32% male and 15.68% female) with splenic injury were admitted to hospital. The mean duration of hospital stay was 17.9±18.6 days and the gender distribution of splenic injury over the successive years did not differ significantly (P>0.05, c=0.034). However, there was a significant difference in the gender distribution of splenic injury patients in different months (P<0.05, c=0.063). In addition, admission numbers for splenic injury were highest in September, October and November. It was also found that splenic injury may occur at all ages, though patients of working age (20-50 years), which comprises 85.59% of patients, the highest proportion of all recorded cases. Associations between mortality rate and each management strategy were as follows: Operative management, 0.11% and non‑operative management, 0.15%. Furthermore, multivariate analysis demonstrated that transfusion, New Injury Severity Score and management strategies were all correlated with mortality rate. Thus, despite a lack of data for inpatients from civilian hospitals, the present study has, in part, identified the epidemiology and management strategies of splenic injury in China. These findings may supplement those from previous analyses of splenic injury in other countries and regions.


  • Assessment of the protective performance of hood using head FE model in car-to-pedestrian collisions

    by Yong Peng, Yong Han, Yong Chen, Jikuang Yang, Remy Willinger

    The objective of the present study was to present a method to assess the protective performance of a passenger car hood to decrease pedestrian head injuries in car-to-pedestrian collisions by using a validated human head finite element (FE) model. Three types of hoods, sandwich structure hood, multi-cone and wavilness inner-panel hoods, made of aluminium were proposed to protect the pedestrian's head. The head FE model was used to evaluate the protection performance of the proposed hood designs by modelling of head impact to the hood. The head intracranial pressure and the linear and rotational acceleration were measured using the head FE model to predict the risk of brain injury. The results indicated that the proposed hood designs showed a significant improvement in injury mitigation from simulations of the head FE model impact to the hood in the investigated passenger car.


  • Immunohistochemical studies of the expression of matrix metalloproteinase-2 and metalloproteinase-9 in human prostate cancer

    by Zeng Hanqing, Xiao Yajun, Lu Gongchen, Chen Yong

    To study the expression of matrix metalloproteinase-2 and-9 in human prostate cancer, matrix metalloproteinase-2 and-9 were immunohistochemically detected in tissues of prostate cancer and benign prostatic hyperplasia (BPH). Our results showed that matrix metalloproteinase-2 and-9 levels in prostate cancer were much higher than those in tissues of BPH, with the cancer invasion being positively correlated with the expression of the metalloproteinases. It is concluded that matrix metalloproteinase-2 and-9 are better molecular markers, which are of help in the diagnosis and prediction of prognosis of prostate cancer.